Hepatocellular carcinoma

Hepatocellular carcinoma is the most common type of primary liver cancer in adults. It is closely linked to people with chronic liver diseases, such as cirrhosis caused by hepatitis B or hepatitis C infection. Metabolic syndrome and non-alcoholic fatty liver disease are also increasingly recognized as risk factors for this type of cancer.

Showing all 2 results

Filter our product list:
API
Antigen / Target
Therapeutic Areas
Therapeutic Indications
1
Classes of molecule​s
Isotypes
Expiry Date
CoA
Filters Sort results
Reset Apply

Product
Batch

Antigen
Molecular Class
Drug Brand
Product Concentration
CoA
Quantity per vial
Storage Temperature
Expiry Date
Price from
PD-L1
Monoclonal Antibody-Fc engineered
Tecentriq®
60 mg/mL
yes
12 mg
-80°C
03/2022
262,80 
view product
Max: 10
Min: 2
Step: 1
PD-L1
Monoclonal Antibody-Fc engineered
Tecentriq®
60 mg/mL
yes
12 mg
-80°C
05/2023
262,80 
view product
Max: 1
Min: 1
Step: 1

Not looking for Hepatocellular carcinoma?

Search our therapeutic molecules product database